144 related articles for article (PubMed ID: 24224128)
1. Histone demethylase GASC1, a potential prognostic and predictive marker in esophageal squamous cell carcinoma.
Sun LL; Holowatyj A; Xu XE; Wu JY; Wu ZY; Shen JH; Wang SH; Li EM; Yang ZQ; Xu LY
Am J Cancer Res; 2013; 3(5):509-17. PubMed ID: 24224128
[TBL] [Abstract][Full Text] [Related]
2. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.
Berdel B; Nieminen K; Soini Y; Tengström M; Malinen M; Kosma VM; Palvimo JJ; Mannermaa A
BMC Cancer; 2012 Nov; 12():516. PubMed ID: 23148692
[TBL] [Abstract][Full Text] [Related]
4. Histone Demethylase GASC1 Inhibitor Targeted GASC1 Gene to Inhibit the Malignant Transformation of Esophageal Cancer through the NOTCH-MAPK Signaling Pathway.
Li Q; Qu B; Shen H; Deng H; Sun L
Ann Clin Lab Sci; 2022 Mar; 52(2):240-248. PubMed ID: 35414503
[TBL] [Abstract][Full Text] [Related]
5. GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial.
Jia R; Mi Y; Yuan X; Kong D; Li W; Li R; Wang B; Zhu Y; Kong J; Ma Z; Li N; Mi Q; Gao S
J Oncol; 2020; 2020():1607860. PubMed ID: 32411232
[TBL] [Abstract][Full Text] [Related]
6. GASC1 Promotes Stemness of Esophageal Squamous Cell Carcinoma via NOTCH1 Promoter Demethylation.
Jia R; Yang L; Yuan X; Kong J; Liu Y; Yin W; Gao S; Zhang Y
J Oncol; 2019; 2019():1621054. PubMed ID: 31031809
[TBL] [Abstract][Full Text] [Related]
7. GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma.
Uimonen K; Merikallio H; Pääkkö P; Harju T; Mannermaa A; Palvimo J; Kosma VM; Soini Y
Histol Histopathol; 2014 Jun; 29(6):797-804. PubMed ID: 24371038
[TBL] [Abstract][Full Text] [Related]
8. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.
Liu G; Bollig-Fischer A; Kreike B; van de Vijver MJ; Abrams J; Ethier SP; Yang ZQ
Oncogene; 2009 Dec; 28(50):4491-500. PubMed ID: 19784073
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic role of GASC1 in chemically induced mouse skin cancer.
Ozaki Y; Fujiwara K; Ikeda M; Ozaki T; Terui T; Soma M; Inazawa J; Nagase H
Mamm Genome; 2015 Dec; 26(11-12):591-7. PubMed ID: 26248577
[TBL] [Abstract][Full Text] [Related]
11. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3.
Cloos PA; Christensen J; Agger K; Maiolica A; Rappsilber J; Antal T; Hansen KH; Helin K
Nature; 2006 Jul; 442(7100):307-11. PubMed ID: 16732293
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
13. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
[TBL] [Abstract][Full Text] [Related]
14. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
[TBL] [Abstract][Full Text] [Related]
15. Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.
Yang Q; Luo GY; Li Y; Shan HB; Wang HY; Xu GL
Med Oncol; 2013 Dec; 30(4):689. PubMed ID: 24026656
[TBL] [Abstract][Full Text] [Related]
16. Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
Xie JJ; Guo JC; Wu ZY; Xu XE; Wu JY; Chen B; Ran LQ; Liao LD; Li EM; Xu LY
Hum Pathol; 2016 Feb; 48():69-75. PubMed ID: 26772401
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.
Sun LL; Sun XX; Xu XE; Zhu MX; Wu ZY; Shen JH; Wu JY; Huang Q; Li EM; Xu LY
Acta Histochem; 2013 Jan; 115(1):56-62. PubMed ID: 22534467
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
19. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
20. Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma.
Li M; Tang Y; Zang W; Xuan X; Wang N; Ma Y; Wang Y; Dong Z; Zhao G
Diagn Pathol; 2013 Mar; 8():47. PubMed ID: 23531395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
